Epilepsy
The Epilepsy pipeline: 73 tracked drugs, 47 approved for this indication.
47 approved / phase 411 Phase 32 Phase 2/36 Phase 24 Phase 1/23 Phase 1
Compare the share prices of listed companies in Epilepsy →
Total attributable cost
$15.6B
$4,580/patient
Drug spend
Not yet sourced
All severities (active epilepsy) · US
The Epilepsy pipeline
Key trial results for every approved and late-stage drug: Epilepsy results by drug.